Khiron Announces Restricted Share Unit Grants
Khiron Announces Restricted Share Unit Grants
Canada NewsWire
TORONTO, Aug. 26, 2020
TORONTO, Aug. 26, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announced that it has granted a total of 1,140,000 restricted share units (RSUs) to certain directors and officers of the Company and its subsidiaries under the Company's Amended and Restated RSU Plan.
Security | Number | Grant Date | Vesting | |
RSUs | 600,000 | August 26, 2020 | 1/3 vest on grant date; 1/3 vest on each of the first | |
RSUs | 500,000 | August 26, 2020 |
A quarter on the | Number of RSUs
125,000
|
A quarter on the | 125,000 | |||
A quarter on the
A quarter on the
| 125,000
125,000 | |||
Total: | 500,000 | |||
RSUs | 40,000 | August 26, 2020 | 1/3 vest on each of the first, second and third | |
About Khiron Life Sciences Corp.
Khiron is a vertically integrated medical and CPG cannabis company with core operations in Latin America, and operational activity in Europe and North America. Khiron is the leading cannabis company in Colombia and the first company licensed in Colombia for the cultivation, production, domestic distribution, and international export of both low and high THC medical cannabis products. The Company has presence in Mexico, Peru, Uruguay, Brazil, UK, Spain and Germany, where it is positioned to begin sales of medical cannabis.
Leveraging its first-mover advantage, and patient-oriented approach, Khiron combines global scientific expertise, product innovation, agricultural infrastructure, wholly-owned medical clinics, and online doctor education programs to drive prescription and brand loyalty to address priority medical conditions. Its Wellbeing unit launched the first branded CBD skincare brand in Colombia, with KuidaTM now marketed in multiple jurisdictions in Latin America, the US and UK. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors.
Visit Khiron online at www.khiron.ca, investors.khiron.ca and on Instagram @khironlife.
Neither the TSX Venture Exchange Inc. ("TSXV") nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.
View original content to download multimedia:http://www.prnewswire.com/news-releases/khiron-announces-restricted-share-unit-grants-301119163.html
SOURCE Khiron Life Sciences Corp.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/August2020/26/c1346.html
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.